Needham Reiterates Hold on Medtronic
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Hold rating on Medtronic (NYSE:MDT).
May 24, 2024 | 9:30 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst Mike Matson has reiterated a Hold rating on Medtronic. This suggests that the analyst does not see significant upside or downside potential in the short term.
The Hold rating indicates that the analyst believes Medtronic's stock is fairly valued at its current price. This suggests limited short-term price movement, either up or down.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100